Tuesday, November 29, 2022
HomePress ReleaseEIN PresswireHome Infusion Therapy Market 2021 Size, Share, Trends, Analysis and Research Report...

Home Infusion Therapy Market 2021 Size, Share, Trends, Analysis and Research Report 2026 – IMARC Group


Home Infusion Therapy Market

SHERIDAN, WY, UNITED STATES, April 22, 2022 /EINPresswire.com/ — According to the latest report by IMARC Group, titled “Home Infusion Therapy Market Size: Global Industry Trends, Share, Growth, Opportunity and Forecast 2021-2026,” provide the global home infusion therapy market exhibited moderate growth during 2015-2020 and expects the market to grow at a CAGR of around 7% during 2021-2026. The report provides a detailed analysis of the market by region, product and application, the report analyzes the market’s competitive landscape.

Report Metric

Historical: 2015-2020

Base Year: 2020

Forecast Year: 2021-2026

Download free sample of the report: https://www.imarcgroup.com/home-infusion-therapy-market/requestsample

Home Infusion Therapy Market Industry Definition and Application:

Home infusion therapy refers to a medical procedure used in the intravenous (IV) or subcutaneous administration of drugs or biologics to a patient at home. It involves the infusion of medications like antivirals or immune globulin through pumps, vials, catheters, etc. This method is effective in chemotherapy and hydration, inotropic, enteral, anti-infective, nutritional, and pain management therapies for the treatment of diabetes and different gastrointestinal and oncological disorders. Besides this, it facilitates self-administration of drugs in medical conditions where oral medications are not effective.

Note: We are regularly tracking the direct effect of COVID-19 on the market, along with the indirect influence of associated industries. These observations will be integrated into the report.

Home Infusion Therapy Market Trends and Drivers:

The increasing cases of chronic medical ailments, like cancer, osteoarthritis, diabetes, etc., and shifting consumer preferences towards at-home treatments are primarily driving the global market for home infusion therapy. Moreover, the growing incidences of hospital-acquired infections (HAIs) upon exposure to contaminated equipment, bed linens, air droplets, etc., is also driving the demand for home infusion treatment. Additionally, the ongoing global COVID-19 pandemic is escalating the need for this therapy to minimize the spread of infection and ensuring optimal treatment. Additionally, the development of cost-effective, portable, and user-friendly home infusion kits that are equipped with advanced drip systems to facilitate precise and real-time monitoring of IV treatments is further contributing to the market growth. Besides this, the expanding geriatric population and improving healthcare infrastructures are anticipated to further propel the market growth in the coming years.

Browse full report with TOC: https://bit.ly/39xhrSU

Home Infusion Therapy Market Segmentation:

The report has segmented the market on the basis on region, product and application.

Breakup by Product:

Infusion Pumps
Elastomeric
Electromechanical
Gravity
Others
Intravenous Sets
IV Cannulas
Needleless Connectors

Breakup by Application:

Anti-Infective
Endocrinology
Diabetes
Others
Hydration Therapy
Athletes
Others
Chemotherapy
Enteral Nutrition
Parenteral Nutrition
Specialty Pharmaceuticals
Others

Breakup by Region:

North America:( United States, Canada)
Asia-Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)
Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)
Latin America: (Brazil, Mexico,Others)
Middle East and Africa

Who are the Major Home Infusion Therapy Market Key players?

The report provides a detailed analysis of the market leaders, including.

B. Braun Melsungen AG, Baxter International Inc., Becton Dickinson and Company, Eli Lilly and Company, Fresenius SE & Co. KGaA, ICU Medical Inc., JMS Co. Ltd., Nipro Corporation, Option Care Health Inc. (Walgreen Co.), Smiths Group plc and Terumo Corporation.

Browse related reports:

Fractional Flow Reserve Market Report 2021-26

Uveitis Treatment Market: https://bit.ly/3uJOHlK

GCC Telemedicine Market: https://bit.ly/3JmmMfG

Cone Beam Imaging Market: https://bit.ly/3BiqsvZ

Glaucoma Therapeutics Market Report

Atherectomy Devices Market: https://bit.ly/3LqVnuG

COVID-19 Diagnostics Market: https://bit.ly/3oIZQzf

Glaucoma Therapeutics Market: https://bit.ly/34SdRU3

Companion Diagnostics Market Report 2021-26: https://bit.ly/3t931li

About Us

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC’s information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company’s expertise.

Elena Anderson
IMARC Services Private Limited
+1 6317911145
email us here





Source link

RELATED ARTICLES

Most Popular